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ABSTRACT
Introduction Impaired coordination between 
breathing and swallowing (breathing–swallowing 
discoordination) may be a significant risk factor for 
the exacerbation of chronic obstructive pulmonary 
disease (COPD). We examined breathing–swallowing 
discoordination in patients with COPD using a non-
invasive and quantitative technique and determined its 
association with COPD exacerbation.
Methods We recruited 65 stable outpatients 
with COPD who were enrolled in our prospective 
observational cohort study and did not manifest an 
apparent swallowing disorder. COPD exacerbation 
was monitored for 1 year before and 1 year after 
recruitment. Swallowing during inspiration (the I-SW 
pattern) and swallowing immediately followed by 
inspiration (the SW-I pattern) were identified.
Results The mean frequency of the I-SW and/or 
SW-I patterns (I-SW/SW-I rate) was 21.5%±25.5%. 
During the 2-year observation period, 48 exacerbation 
incidents (25 patients) were identified. The I-SW/SW-I 
rate was significantly associated with the frequency of 
exacerbation. During the year following recruitment, 
patients with a higher I-SW/SW-I frequency using 
thicker test foods exhibited a significantly higher 
probability of future exacerbations (p=0.002, log-rank 
test).
Conclusions Breathing–swallowing discoordination 
is strongly associated with frequent exacerbations of 
COPD. Strategies that identify and improve breathing–
swallowing coordination may be a new therapeutic 
treatment for patients with COPD.
InTRoduCTIon
Chronic obstructive pulmonary disease 
(COPD) is a common life-threatening lung 
disease worldwide. In the management of 
patients with COPD, prevention of COPD 
exacerbation is one of most important goals 
because exacerbation has serious impacts on 
the morbidity, mortality and healthcare costs 
associated with COPD.1 2 Therefore, identi-
fying and reducing the risk factors associated 
with COPD exacerbation are major thera-
peutic targets in clinical settings.
In our previous study, gastro-oesophageal 
reflux (GER) symptoms were found to be 
associated with frequent COPD exacerba-
tion,3 and various replication studies have 
been conducted.4–6 However, treating GER 
symptoms simply with a proton pump inhib-
itor does not reduce COPD exacerbation.7 
This result suggests that something else is 
associated with GER that may be important 
to prevent COPD exacerbation rather than 
the GER symptom itself. Because most 
patients with COPD are old, they may exhibit 
various functional abnormalities, including 
swallowing abnormalities.3 8–10 In another 
previous report by our group,11 we elucidated 
the association between GER and impaired 
swallowing abnormalities in patients with 
COPD; the results suggested that swallowing 
abnormalities and subsequent aspiration may 
exacerbate COPD.
To assess these swallowing abnormali-
ties, we recently developed a non-invasive 
and quantitative technique for measuring 
breathing–swallowing coordination.12 Using 
this technique, we can monitor breathing and 
swallowing as a time series and identify the 
respiratory phase sequence, overlap and delay 
of inspiration/expiration and swallowing. 
In particular, according to a recent study by 
Gross et al,13 swallowing during inspiration 
(I-SW pattern) and swallowing immediately 
followed by inspiration (SW-I pattern) may be 
notable signs of breathing–swallowing disco-
ordination. However, there is not sufficient 
information about such discoordination in 
patients with COPD, and it remains unclear 
whether breathing–swallowing discoordina-
tion is a meaningful feature and useful index 
in patients with COPD.14 15
We hypothesised that breathing–swal-
lowing coordination may be impaired in 
patients with COPD and that breathing–
swallowing ‘discoordination’ may be a 
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The present study was part of our prospective observa-
tional cohort study at Kyoto University. From patients 
who were enrolled in this cohort study, 65 stable outpa-
tients with COPD who met the criteria and gave written 
informed consent were recruited into the present study 
(all male, 71.9±8.4 years old). Recruitment for the 
present study and swallowing monitoring measurements 
were conducted between May 2015 and October 2016. 
The present study was approved by the local ethical 
committee of Kyoto University (C841). The detailed 
inclusion and exclusion criteria for the present study are 
listed in online supplement e-table 1. Briefly, patients 
were aged 40 years or older, diagnosed with COPD 
by the Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) criteria16 and in stable condition at the 
recruitment visit (day 0). In addition, patients with an 
apparent swallowing disorder, clinically evident cerebro-
vascular diseases, dementia or a cardiac pacemaker were 
excluded (online supplement e-table 1).
At the recruitment visit, patients conducted a 
swallowing function analysis (monitoring of breathing–
swallowing coordination), pulmonary function test and 
questionnaires, which included respiratory symptoms, 
GER symptoms and their dietary situation.
To evaluate respiratory symptoms, the COPD Assess-
ment Test (CAT)17 and modified Medical Research 
Council Dyspnoea Scale were used. GER symptoms were 
evaluated with a self-reported frequency scale for symp-
toms of GERD (FSSG) questionnaire.18 The cut-off score 
for GERD was set at 8 points. Subject’s dietary situations 
were assessed with the Food Intake Level Scale (FILS)19 
and the Functional Oral Intake Scale (FOIS).20
Stable COPD was defined as a period of at least 4 weeks 
without any worsening respiratory symptoms assessed by 
a symptom diary, as in our previous studies.3 11
exacerbation criteria
We evaluated the number of COPD exacerbation inci-
dents from 1 year before and 1 year after the recruitment 
visit (day 0). The number of exacerbation-free days after 
day 0 was also investigated. All patients were asked to 
use a symptom diary that was described in our previous 
reports in detail.3 21 The diary includes records of ‘major’ 
symptoms and ‘minor’ symptoms, as well as the usage of 
additional treatments for COPD. COPD exacerbation 
was defined as the occurrence of two or more major 
symptoms or any one major symptom with any one minor 
symptom for at least 2 consecutive days, concomitant 
with a change in daily pharmacotherapy (see the online 
supplement).
Swallowing monitoring system and analysis methods
We used a non-invasive swallowing monitoring system 
using respiratory flow, swallowing sound and laryngeal 
movement.12 After setting up the swallowing monitoring 
system, patients assumed an upright sitting position with 
an intermediate head position22 and swallowed four types 
of test foods twice each (a total of eight times). Patients 
were instructed not to chew the test foods and to swallow 
voluntarily.
System configurations are presented in figure 1. 
The monitoring system consists of a nasal cannu-
la-type flow sensor, a film-type piezoelectric sensor and 
signal processing units. Figure 2 shows an example of 
a breathing–swallowing coordination pattern analysed 
by this system. Using a series of the respiratory flow, the 
laryngeal sound and motion data, we evaluated (1) the 
duration of deglutition apnoea and swallowing latency 
and (2) breathing–swallowing coordination. Detailed 
information about the analysis is available in the online 
supplement. Figure 2A shows a usual pattern, such as 
the expiration–swallow–expiration pattern. Figure 2B,C 
shows two unusual patterns (I-SW and SW-I, respectively). 
These two unusual patterns may even occur in healthy 
subjects, although less frequently. The occurrence of 
these two unusual patterns (I-SW and/or SW-I) may indi-
cate breathing–swallowing discoordination.13
Test foods
We adopted the Japanese ‘Level’ system to describe the 
specifications of the test foods, which was standardised 
by the Japanese Society of Dysphagia Rehabilitation.23 
The test foods we used included level 0 (soft jelly), level 
2 (hard jelly), level 3 (purée) and water. The properties 
(hardness, cohesion and adhesion) of these test foods 
were strictly controlled.12 One piece of test food weighed 
approximately 3 g, and 3 mL of water was injected using 
a syringe.
Statistical analyses
The results associated with patient characteristics are 
presented as frequencies for categorical variables and 
means±SDs and ranges for continuous variables unless 
otherwise specified. Comparisons of the variables between 
patients with and without exacerbation during the 2-year 
observation trial were performed using the χ2 test or 
Fisher’s exact test for categorical variables and t-tests 
for continuous variables. Univariate analyses between 
the frequency of exacerbation and the breathing–swal-
lowing coordination index, pulmonary function or other 
parameters were performed, and multivariate regression 
analyses using three different models were subsequently 
performed.
To evaluate the predictive ability of the breathing–swal-
lowing coordination index, we also used the Kaplan-Meier 
method, the log-rank test and the Cox proportional 
hazards model, using time-to-event data of exacerbation 
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incidents during half of the observation period (1 year 
after the recruitment).
All statistical analyses were performed using JMP11 (SAS 
Institute Inc., Cary, NC, USA). In all instances, a two-sided 




The anthropometric, symptomatic and pathophysiolog-
ical patient characteristics are shown in table 1. One-third 
of patients (n=21) were classified as having severe or very 
severe airflow limitation (GOLD III or IV), and all subjects 
were at FILS level 10 and FOIS level 7, confirming that 
the subjects did not have an apparent swallowing disorder 
at recruitment. All patients completed the entire 2 -year 
observation period for COPD exacerbation. In total, 25 
out of 65 patients experienced COPD exacerbation (48 
incidents). The frequency of exacerbation was 0.37 inci-
dents per patient per year in the present study. Patients 
who experienced exacerbation showed significantly more 
severe pulmonary dysfunction (forced expiratory volume 
in 1 s (FEV1)/forced vital capacity (FVC), diffusing 
capacity of carbon monoxide (DLco)), severe respiratory 
symptoms (CAT) and a higher prevalence of GER symp-
toms (FSSG ≥8) than patients who did not experience 
exacerbation (table 2).
From the breathing–swallowing monitoring, the 
frequencies of the I-SW and/or SW-I patterns in patients 
with COPD were 21.5%±25.5%. Patients with COPD in the 
present study seemed to have relatively higher frequencies 
of I-SW/SW-I than healthy subjects in our previous report 
(11.6%±18.0%).12 This breathing–swallowing disco-
ordination did not show significant associations with 
pulmonary dysfunction or respiratory symptoms (online 
supplement  e-table 2); however, the frequency of I-SW/
SW-I was significantly higher in patients who experienced 
exacerbation (p<0.001, table 2).
univariate and multivariate analyses of CoPd exacerbation
Table 3 shows the results of univariate analyses in which 
the dependent variable is the frequency of exacerba-
tion. The frequencies of I-SW/SW-I, %FEV1, FEV1/FVC, 
%vital capacity (%VC) and DLco were significantly asso-
ciated with the frequency of exacerbation. In addition, 
patients with GER symptoms (FSSG ≥8) showed a high 
frequency of exacerbation (0.6 vs 0.25/year, p<0.05).
We subsequently performed multivariate analyses using 
three different sets of independent variables (table 4). 
We selected the I-SW/SW-I rate, GER symptoms, %FEV1 
and inspiratory capacity (IC)/total lung capacity (TLC) 
as candidates for independent variables, taking their 
significance in the univariate analysis as well as previous 
reports into account. Multivariate analyses with the set 
of I-SW/SW-I rate, %FEV1 and IC/TLC (model 1), with 
the set of variables replacing I-SW/SW-I rate with GER 
symptoms in model 1 (model 2) and with all candidates 
(model 3) indicated that both the I-SW/SW-I rate and 
IC/TLC were good independent predictors of COPD 
exacerbation (p<0.05).
In addition, we evaluated whether the occurrence of 
the I-SW/SW-I patterns differed depending on the type 
Figure 1 A schematic diagram of the swallowing monitor.
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of test food. As shown in table 5, the number of patients 
with I-SW/SW-I patterns was the lowest for level 0 jelly, 
that is, the safest test food, and largest for level 3 purée, 
the food most difficult to swallow among the test foods. 
Interestingly, the associations between the frequency of 
I-SW/SW-I and the frequency of exacerbation were stron-
gest for level 0 jelly (r=0.44, p<0.001).
Kaplan-Meier curve
To evaluate the predictive ability of breathing–swal-
lowing discoordination for future exacerbation, we 
performed an additional investigation using only the 
latter half of the observation period, 1 year after the 
measurement of breathing–swallowing coordination 
at recruitment. During this later observation period, 
COPD exacerbation occurred in 16 patients. We 
selected a 25% average frequency of I-SW/SW-I as the 
cut-off value according to the quartile value of a healthy 
Figure 2 Coordination between breathing and swallowing. 
Swallowing occurs during expiration, and respiration 
resumes with expiration (A: E–SW–E pattern). Swallowing 
occurs during inspiration (B: I-SW pattern), and respiration 
resumes with inspiration (C: SW-I pattern). The I-SW and 
SW-I patterns are unusual patterns, but may even occur in 
healthy subjects. E–SW–E, expiration–swallow–expiration; 
I-SW, swallowing during inspiration; SW-I, swallowing 
immediately followed by inspiration.
Table 1 Patients’ characteristics
Variable Mean±SD (range)
Total number of patients 65
Age, years 71.9±8.4 (46–89)
Sex, male/female 65/0
Height, cm 164.6±6.3 (145.3–178)
Weight, kg 60.5±9.4 (41.5–88)
BMI, kg/m2 22.3±3.0 (16–31.6)
Smoking status, former/current 60/5
Smoking history, pack-years 63.2±32.4 (18–184)
FSSG score 6.1±6.04 (0–36)
GER symptoms (FSSG ≥8) 20/45
CAT 11.28±6.97 (1–28)
mMRC Dyspnoea Scale, 
0/1/2/3/4
21/28/13/2
GOLD stage, I/II/III/IV 10/34/14/7
FEV1, L 1.63±0.6 (0.62–2.91)
FEV1, % predicted 58.87±19.74 (17.7–96.9)
FVC, L 3.2±0.8 (1.76–4.99)
FEV1/FVC, % 49.94±13.5 (0.23–100)
VC, L 3.5±0.7 (2.01–4.95)
VC, % predicted 99.61±16 (63–131.7)
IC/TLC, % 37.84±6.63 (24.24–52.91)
RV/TLC, % 40.9±7.5 (27–67)
DLco, mL/min/mm Hg 13.32±5.41 (3.6–28.27)
The continuous variables are presented as the mean±SD (range).
BMI, body mass index; CAT, Chronic Obstructive Pulmonary 
Disease Assessment Test; DLco, diffusing capacity of carbon 
monoxide; FEV1, forced expiratory volume in 1 s; FSSG, frequency 
scale for symptoms of gastro-oesophageal reflux disease; 
FVC, forced vital capacity; GER, gastro-oesophageal reflux; 
GOLD, Global Initiative for Chronic Obstructive Lung Disease; IC, 
inspiratory capacity; mMRC, modified Medical Research Council; 
RV, residual volume; TLC, total lung capacity; VC, vital capacity.
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subject,12 and patients with an I-SW/SW-I rate ≥25% 
were defined as having high breathing–swallowing 
discoordination. Figure 3A shows the Kaplan-Meier 
curves of the high discoordination group (group A, 
n=25) and the low discoordination group (group B, 
n=40). Patients with COPD with high discoordination 
had a higher risk for future exacerbation than patients 
with low discoordination (HR, 2.32; 95% CI 0.86 to 6.50; 
p=0.085 by log-rank test). Furthermore, interestingly, 
if we stratified patients using the I-SW/SW-I rate with 
only level 0 test foods, the high breathing–swallowing 
discoordination group (positive occurrence of I-SW/
SW-I, group A; n=15) was at a significantly higher risk 
for future exacerbation than the low discoordination 
group (no occurrence of I-SW/SW-I, group B; n=50) 
(HR, 4.12; 95% CI 1.51 to 11.23; p=0.002 by log-rank 
test, figure 3B).
dISCuSSIon
We conducted an observational study of patients with 
COPD to gain insight into the clinical significance of 
breathing–swallowing discoordination for frequent 
COPD exacerbation. Our results showed that, even for 
those who did not have apparent dysphagia, breathing–
swallowing discoordination, as indicated by the I-SW/
SW-I rate, contributed to frequent exacerbation. Our 
results further indicate that breathing–swallowing disco-
ordination is associated with the risk of aspiration, and 
interventions focusing on the improvement of breathing–
swallowing discoordination will be good candidates for 
the treatment of patients with COPD.
It has been previously shown that swallowing abnor-
malities are more frequently observed in patients with 
COPD,11 14 and swallowing abnormalities are associated 
Table 2 Patient characteristics stratified by patients who did and did not experience exacerbation during the 2-year 
observation period
Exacerbation during the 2-year observation period
Variable Patients with exacerbation Patients without exacerbation p Value
Total number of patients 25 40
Age, years 73.2±9.1 (46–88) 71.1±7.92 (46–89) 0.321
Height, cm 163.1±7.3 (145.3–175.9) 165.6±5.5 (149.8–178) 0.118
Weight, kg 59.0±11.0 (41.5–88) 61.4±8.2 (41.9–85) 0.332
BMI, kg/m2 22.1±3.6 (16–31.6) 22.4±2.5 (16.3–27.1) 0.782
Smoking status, former/current 25/0 35/5 0.147
Smoking history, pack-years 57.2±29.8 (24.8–153) 67.0±33.7 (18–184) 0.239
FSSG score 7.3±5.8 (0–19) 5.3±6.1 (0–36) 0.186
GER symptoms (FSSG ≥8) 12/25 8/40 0.017
CAT 13.4±7.2 (1–28) 9.9±6.6 (1–27) 0.047
mMRC Dyspnoea Scale, 0/1/2/3/4 4/15/5/1/0 17/13/8/1/0 0.106
GOLD stage, I/II/III/IV 2/14/5/4 7/21/10/2 0.358
FEV1, L 1.41±0.61 (0.62–2.82) 1.75±0.61 (0.66–2.91) 0.028
FEV1, %predicted 53.7±19.9 (17.7–96.9) 62.1±19.2 (22.7–92.9) 0.095
FVC, L 3.03±0.7 (1.8–4.3)±0.7(1.8–4.3) 3.3±0.8(1.8–5.0) 0.147
FEV1/FVC, % 45.5±13.0 (23.3–65.9) 52.6±13.2 (0.3–100) 0.037
VC, L 3.2±0.7 (2.0–4.5) 3.7±0.7 (2.5–5.0) 0.011
VC, % predicted 95.2±17.5 (63–124.1) 102.4±14.53 (73.3–131.7) 0.083
IC/TLC, % 35.8±7.1 (24.2–47.1) 39.1±6.1 (26.1–52.9) 0.051
RV/TLC, % 42.0±7.7 (27.1–54.8) 40.2±7.43 (28.9–67.2) 0.373
DLco, mL/min/mm Hg 11.5±4.4 (6.7–21.8) 14.4±5.7 (3.6–28.3) 0.032
I-SW/SW-I rate 32.5±31.1 (0–87.5) 14.6±18.7 (0–75) 0.005
Swallowing latency, s 519.6±584.2 (−99.9–2031.5) 276.8±362.8 (−141.9–1641.5) 0.042
Apnoea duration, ms 1.6±0.8 (0.5–3.1) 1.3±0.6 (0.4–2.6) 0.074
The continuous variables are presented as the mean±SD (range).
BMI, body mass index; CAT, Chronic Obstructive Pulmonary Disease Assessment Test; DLco, diffusing capacity of carbon monoxide; FEV1, 
forced expiratory volume in 1 s; FSSG, frequency scale for symptoms of gastro-oesophageal reflux disease;  GER, gastro-oesophageal 
reflux; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; IC, inspiratory capacity; I-SW, swallowing 
during inspiration; mMRC, modified Medical Research Council; RV, residual volume; SW-I, swallowing immediately followed by 
inspiration; TLC, total lung capacity; VC, vital capacity.
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with cough sensitivity and GER symptoms.11 Because GER 
symptoms are one of the most important extrapulmonary 
predictive factors of frequent COPD exacerbation, we can 
assume that the relationship between GER symptoms and 
swallowing abnormalities, as well as aspiration disorders, 
will have clinical impacts including a high risk of COPD 
exacerbation. It remains unclear whether it is possible 
to improve breathing–swallowing discoordination in 
patients with COPD, although Martin-Harris et al showed 
that it was possible to improve swallowing function with 
a biofeedback approach for breathing–swallowing disco-
ordination in postoperative patients with head and neck 
cancer.24 Therefore, breathing–swallowing discoordi-
nation may be a therapeutic target for the reduction of 
exacerbation in patients with COPD.
Swallowing abnormalities in patients with COPD have 
been reported by our colleague11 and Cassiani et al14 
previously; however, these reports employed invasive 
or cumbersome techniques, such as injections through 
a nasal catheter and videofluoroscopy, which require 
additional imaging procedures or radiation exposure. 
We used a new non-invasive and quantitative technique 
to evaluate breathing–swallowing discoordination and 
found the frequencies of the I-SW and/or SW-I patterns 
to be a promising index for the risk of COPD exacer-
bation. As mentioned above, our method has certain 
advantages, such as quantitative capability, non-inva-
siveness and easiness to repeat, compared with other 
techniques. In addition, even in patients who did not 
show apparent swallowing problems, our technique 
successfully revealed latent breathing–swallowing disco-
ordination in patients with COPD. Moreover, the index 
of discoordination (I-SW/SW-I rate) was revealed as a 
good predictive marker for frequent COPD exacerbation 
(figure 3).
Although we did not compare patients with COPD with 
normal healthy subjects directly in the present study, the 
frequencies of I-SW/SW-I seemed to be higher in patients 
with COPD than normal healthy subjects.12 A similar 
pattern was already reported in patients with COPD13 as 
well as patients with Parkinson’s disease,25 and patients 
with Parkinson's disease showed a significant association 
between breathing–swallowing discoordination and the 
risk of laryngeal penetration/aspiration.26 We still need 
to clarify whether this breathing–swallowing abnormality 
is associated with physiological abnormalities due to respi-
ratory disease. We speculated that breathing–swallowing 
Table 3 Univariate analysis in terms of the frequency of 
exacerbation
Factor r 95% CI p Value
Age 0.21 −0.037 to 0.43 0.095








Swallowing latency 0.29 0.046 to 0.50 0.020
FSSG score 0.12 −0.13 to 0.35 0.341




FEV1 −0.30 −0.51 to −0.06 0.013
%FEV1 −0.24 −0.45 to 0.008 0.057
FVC −0.21 −0.43 to 0.035 0.093
FEV1/FVC −0.27 −0.48 to −0.03 0.028
VC −0.32 −0.53 to −0.09 0.007
%VC −0.25 −0.47 to −0.001 0.049
IC/TLC −0.35 −0.54 to −0.11 0.004
RV/TLC 0.23 −0.01 to 0.45 0.064
DLco −0.36 −0.55 to −0.12 0.003
BMI, body mass index; CAT, Chronic Obstructive Pulmonary 
Disease Assessment Test; DLco, diffusing capacity of carbon 
monoxide; FEV1, forced expiratory volume in 1 s; FSSG, frequency 
scale for symptoms of gastro-oesophageal reflux disease; FVC, 
forced vital capacity; IC, inspiratory capacity; I-SW, swallowing 
during inspiration; mMRC, modified Medical Research Council; 
r, Pearson’s correlation coefficient; RV, residual volume; SW-
I, swallowing immediately followed by inspiration; TLC, total lung 
capacity; VC, vital capacity. 
Table 4 Multivariate regression analysis in terms of the frequency of exacerbation
Model 1 Model 2 Model 3
β 95% CI p Value β 95% CI p Value β 95% CI p Value
I-SW/SW-I rate 0.37 0.69 to 2.62  <0.001 — — — 0.33 0.48 to 2.49 0.004
GER symptom 
(FSSG ≥8)
— — — 0.23 0.0001 to 1.12 0.049 0.13 −0.22 to 0.88 0.243
%FEV1 −0.07 −1.86 to 0.98 0.535 −0.06 −1.88 to 1.12 0.613 −0.06 −1.79 to 1.04 0.597
IC/TLC −0.31 −1.17 to −0.31 0.013 −0.28 −9.37 to −0.41 0.032 −0.30 −9.42 to −0.30 0.016
Cumulative R2 0.27 0.18 0.29
FEV1, forced expiratory volume in 1 s; FSSG, frequency scale for symptoms of gastro-oesophageal reflux disease; GER, gastro-oesophageal 
reflux; IC, inspiratory capacity; I-SW, swallowing during inspiration; SW-I, swallowing immediately followed by inspiration; TLC, total lung 
capacity.
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discoordination may be affected by pulmonary hyperin-
flation and dyspnoea, but the frequency of I-SW/SW-I 
was not significantly associated with the severity of airflow 
limitation. Therefore, we can assume that the I-SW and 
SW-I patterns are more related to the subject’s ‘extrapul-
monary’ traits, which could be affected by age or various 
functional abnormalities or diseases (eg, neuromuscular 
disease or cerebrovascular diseases).
Breathing–swallowing discoordination with different food 
ingestion
In the present study, the occurrence of inspiration imme-
diately before or after swallows was most frequently 
observed in level 3 purée swallows (table 5). This finding is 
in agreement with a previous study showing that patients 
with COPD had a significantly higher rate of inhaling 
after swallowing pudding and needed more transit time 
in the pharynx.13 14 These findings indicated the sensi-
tivity of our evaluation, which could detect the influence 
of the test food properties on breathing–swallowing 
coordination. Interestingly, the level 0 jelly swallow, for 
which the number of patients with I-SW/SW-I patterns 
was lowest, was most associated with exacerbation. In 
the Kaplan-Meier analysis, a high prevalence of I-SW/
SW-I with only level 0 test food attained significant differ-
ences between groups in the risk for future exacerbation 
1 year after recruitment, whereas the average I-SW/SW-I 
rate with all four test foods was not significantly different 
(figure 3A, B). The results suggest that level 0 jelly, the 
safest food against aspiration, is most useful for detecting 
the risk of exacerbation. Moreover, in terms of predicting 
future exacerbation, we could employ only one type of 
test food in our evaluations.
The association between exacerbation and lung function
Exacerbation becomes more frequent in patients with 
COPD as the severity of disease increases,4 27 and the 
mortality rate is strongly correlated with FEV1,
28 29 IC/
TLC and DLco.30 These associations are consistent with 
the present results showing that lung functions such 
as %FEV1, FEV1/FVC, VC, IC/TLC and DLco were 
significantly related to exacerbation (table 3). In the 
multivariate regression analysis, the I-SW/SW-I rate and 
GER symptoms were also revealed as significant variables 
associated with the frequency of exacerbation (table 4). 
Because of the small sample size, definitive conclusions 
could not be made, although the I-SW/SW-I rate may 
serve as a better prognostic index for COPD exacerba-
tion than other known indexes.
The association between exacerbation and GeR symptoms
Previous large-scale cohort studies and our previous 
cohort study have indicated that the existence of GER 
symptoms is a major predictor for COPD exacerba-
tion.4 11 31 32 Therefore, we employed an evaluation of 
GER symptoms because GER symptoms are confounding 
variables for frequent exacerbation. By performing 
multivariate regression analyses with different models, 
we identified the significant impact of GER symptoms 
on exacerbation (model 2), as well as breathing–swal-
lowing discoordination (model 1). In model 3, using all 
possible variables, the I-SW/SW-I rate was a significant 
variable, whereas GER symptoms were not (table 4). 
In addition, unexpectedly, the I-SW/SW-I rate did not 
show a significant association with FSSG (online supple-
ment e-table 2). These results could be interpreted to 
indicate that pre-existing breathing–swallowing disco-
ordination causes microaspirations and subsequently 
frequent coughs and increased sputum, causing COPD 
exacerbation. Moreover, GER symptoms may have direct 
influences on gastro-oesophageal problems, not only on 
swallowing disorders.
limitations
First, the number of subjects enrolled in our study was 
relatively small, and only men were included. Further, 
the observation period may not have been long enough, 
as the number of exacerbation events was small (48 exac-
erbation incidents in 65 patients). However, because the 
average frequency of exacerbation (0.37 per patient year) 
was almost the same as in previous reports in Japanese 
patients33 and because we found that GER symptoms had 
a significant impact on frequent exacerbation, we can 
assume that our observations were consistent and can 
be extrapolated to other clinical settings. Nevertheless, a 
large-scale cohort study is required to establish the signif-
icance of breathing–swallowing coordination for COPD 
exacerbation.
Table 5 Association between the occurrence of the I-SW/SW-I patterns and the frequency of exacerbation in each test food
Occurrence of I-SW/SW-I pattern* Frequency of I-SW/SW-I pattern
r† 
95% CI p Value
Level 0 15/65 14.8±29.7 0.44 0.22 to 0.62 <0.001
Level 2 19/65 20.2±34.2 0.29 0.05 to 0.50 0.018
Level 3 24/65 28.1±41.2 0.32 0.08 to 0.53 0.009
Water 23/65 23.2±34.4 0.08 −0.17 to 0.32 0.521
Level 0, smooth jelly food without protein; level 2, rough jelly surface; level 3, purée.
*Number of patients showing I-SW and/or SW-I pattern.
†r, Pearson’s correlation coefficient.
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Second, breathing–swallowing discoordination was 
evaluated only once. We do not know if temporal changes 
exist for breathing–swallowing coordination, whether 
exacerbation affects breathing–swallowing coordina-
tion and whether pulmonary rehabilitation ameliorates 
breathing–swallowing coordination. Future studies 
should focus on interventions to improve breathing–swal-
lowing coordination, and prospective evaluations should 
be conducted to determine whether the improvement of 
breathing–swallowing coordination decreases the likeli-
hood of exacerbation.
Third, as mentioned above, we did not compare the 
patients with healthy subjects in the present study. In addi-
tion, we could not find a significant association between 
the I-SW/SW-I rate and a disease-specific index, such as 
airflow limitation. Breathing–swallowing discoordination 
Figure 3 Kaplan-Meier curves of the probability of chronic obstructive pulmonary disease exacerbation during the year after 
recruitment: (A) stratified by the average I-SW/SW-I frequency with all four test foods; (B) stratified by the occurrence of I-SW/
SW-I with level 0 test foods. I-SW, swallowing during inspiration; SW-I, swallowing immediately followed by inspiration.
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occurs even in healthy subjects, and its frequency may 
increase in older populations or people with certain 
disease states (eg, Parkinson’s disease). Moreover, we do 
not know the physiological mechanism of breathing–
swallowing discoordination. Thus, further studies are 
necessary to elucidate the mechanisms of breathing–swal-
lowing discoordination in patients with COPD.
ConCluSIonS
We conclude that breathing–swallowing discoordina-
tion is an independent, strong predictor of exacerbation 
in patients with COPD. Even in patients without an 
apparent swallowing disorder, the evaluation and early 
intervention for breathing–swallowing discoordination 
may prevent exacerbation and consequently improve the 
prognosis of patients with COPD.
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